December 6, 2025: The U.S. Food and Drug Administration (US FDA) in November 2025 has approved reformulated ranitidine tablets, marking the return of this important H₂ receptor antagonist to the U.S. market after a five-year absence. The approval follows extensive safety testing and manufacturing improvements that ensure product quality thr...
Subscribe in seconds and receive Medical News, Health News Latest, Medical News Today - Medical Dialogues |'s news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow Medical News, Health News Latest, Medical News Today - Medical Dialogues |: Medical News, Health News Latest, Medical News Today - Medical Dialogues |
